Biosecure Act MIA from US defense bill in key win for China biopharma service providers
Fierce Pharma
DECEMBER 9, 2024
Mon.Dec 09, 2024
212 
GSK Multiple Myeloma Drug’s DREAMM Comeback Continues With Phase 3 Data at ASH
MedCity News
DECEMBER 9, 2024
Results from the Phase 3 DREAMM-7 study show GSK drug Blenrep is helping multiple myeloma patients live longer compared to treatment with blockbuster Johnson & Johnson drug Darzalex. The data, presented Monday during the annual meeting of the American Society of Hematology, are part of a submission now under FDA review that could lead to Blenreps return to the market.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Amgen's Blincyto keeps 96% of pediatric leukemia patients alive and disease-free in 'practice changing' 3-year study
Fierce Pharma
DECEMBER 9, 2024
Reprieve for Chinese biotechs as BIOSECURE Act left out of key bill
Pharmaceutical Technology
DECEMBER 9, 2024
Shares in WuXi AppTec, one of those implicated in the Chinese biotech blacklisting legislation, surged following the omission.
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Merck gets rare win with Keytruda-Lynparza combo but role of Keytruda in ovarian cancer 'remains uncertain'
Fierce Pharma
DECEMBER 9, 2024
Citryll gains Series B funds to develop NET-targeting antibody
Pharmaceutical Technology
DECEMBER 9, 2024
Citryll has secured an oversubscribed Series B funding round, raising 85m ($89.8m) to advance the clinical development of CIT-013.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Imfinzi receives NICE recommendation for lung cancer treatment
PharmaTimes
DECEMBER 9, 2024
Trial results lead to new treatment option for lung cancer
ASH: With survival win against J&J's Darzalex, GSK bolsters case for return of myeloma ADC Blenrep
Fierce Pharma
DECEMBER 9, 2024
A Lifetime Guarantee on a Shoulder Implant? This Device Maker Is Offering It Through Geisinger
MedCity News
DECEMBER 9, 2024
Swiss Medtech Company Medacta teamed up with Geisinger to begin providing the world’s first, lifetime guarantee on shoulder replacement surgeries. The post A Lifetime Guarantee on a Shoulder Implant? This Device Maker Is Offering It Through Geisinger appeared first on MedCity News.
ASH: Catching up with bispecific rival AbbVie, Roche's subcutaneous Lunsumio matches IV version in lymphoma
Fierce Pharma
DECEMBER 9, 2024
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Cala Health Snags $50M for At-Home Tremor Relief Therapy
MedCity News
DECEMBER 9, 2024
Cala Health closed a $50 million funding round. The Silicon Valley-based company sells an FDA-cleared wearable device that temporarily relieves hand tremors in people with essential tremor and Parkinsons disease. The post Cala Health Snags $50M for At-Home Tremor Relief Therapy appeared first on MedCity News.
EuroAPI vaults operating chief into CEO role as it embarks upon 'new chapter'
Fierce Pharma
DECEMBER 9, 2024
Richard Charkin on South Carolina’s Charleston Conference
Copyright Clearance Center
DECEMBER 9, 2024
Richard Charkin makes his first trip to the Charleston Conference of scholarly librarians and publishers.
Poolbeg Pharma presents positive results for POLB 001
PharmaTimes
DECEMBER 9, 2024
promising pre-clinical data on preventing cytokine release syndrome
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Psychedelics haven’t fulfilled clinical expectations, but new trial strategies could turn the tide
PharmaVoice
DECEMBER 9, 2024
How AI Can Close the Gap in Evidence-Based Care
MedCity News
DECEMBER 9, 2024
With evidence generated in minutes, the days of broad-based guidelines will be gone, as researchers and clinicians will have personalized evidence at their fingertips that can transform value-based care. The post How AI Can Close the Gap in Evidence-Based Care appeared first on MedCity News.
How Can Employers Give Staff the Best Care Amidst Rising Healthcare Costs?
MedCity News
DECEMBER 9, 2024
A webinar on Thursday, December 12 from Noon to 1 pm ET will focus on how companies are meeting these challenges. The post How Can Employers Give Staff the Best Care Amidst Rising Healthcare Costs? appeared first on MedCity News.
Soft Skills That Make You Shine in Medical Sales
Contrarian Sales Techniques
DECEMBER 9, 2024
When people think of medical sales, they often picture a rep armed with clinical data and technical knowledge, pitching the latest pharmaceutical product or medical device. But what truly sets successful reps apartespecially in multinational pharmaceutical companies (MNCs) is not just what they know, but how they connect. Soft skills, often underestimated, are the secret sauce behind thriving in this fast-paced, relationship-driven industry.
ASHP Midyear: Nearly Half of Adults With Epilepsy Use CBD Products
Pharmacy Times
DECEMBER 9, 2024
Adults with epilepsy are underrepresented in most CBD trials, including common etiologies.
Increase Revenue With Better, Faster Sales Onboarding
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Everything You Need to Know About Prior Authorizations in Healthcare
Referral MD
DECEMBER 9, 2024
Prior authorization is a pivotal component of healthcare, bridging the relationship between patients, healthcare providers, and insurance companies. While it can seem complex and frustrating, prior authorization is vital in balancing quality care and cost efficiency. This blog outlines the essentials of prior authorization what it is, why it exists, the steps involved, and how the process can be improved.
Daiichi Sankyo secures breakthrough designation for NSCLC treatment
Pharmaceutical Technology
DECEMBER 9, 2024
The breakthrough designation for Daiichi Sankyo comes after early pooled results from two ongoing trials finding the drug was well tolerated.
Novo Holdings’ acquisition of Catalent gains EC approval
Pharmaceutical Technology
DECEMBER 9, 2024
Novo Holdings, the investment arm of the Novo Nordisk Foundation, has gained approval from the EC for its acquisition of Catalent.
Phase 3 CEPHEUS Trial: DARA Plus VRd Is a Standard of Care for Frontline Treatment in Transplant-Ineligible Multiple Myeloma
Pharmacy Times
DECEMBER 9, 2024
The phase 3 CEPHEUS trial demonstrated that adding daratumumab (DARA) to the VRd regimen significantly improves minimal residual disease negativity, progression-free survival, and overall response in transplant-ineligible or transplant deferred patients with newly diagnosed multiple myeloma, establishing a new standard of care.
Priority FDA review given to AstraZeneca’s Imfinzi sBLA for MIBC
Pharmaceutical Technology
DECEMBER 9, 2024
The US FDA has granted priority review to AstraZeneca's sBLA for Imfinzi (durvalumab) for muscle-invasive bladder cancer (MIBC) treatment.
ASH 2024: Circulating Tumor Cells Can Serve as Biomarker for Poor Outcomes in Multiple Myeloma
Pharmacy Times
DECEMBER 9, 2024
Luca Bertamini, MD highlights the potential clinical implications of using circulating tumor cells as a biomarker in patients with newly-diagnosed multiple myeloma.
Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Let's personalize your content